 |
|
|
|
| Zhu Rongji,Premier of the State Council
meets with some of the distinguished guests participating
in the High-tech Week activities |
|
|
|
|
| Li Lanqing, Vice Premier
of the State Council, makes a keynote speech at the opening
ceremony of the 4th International Week |
|
|
|
|
|
|
|
|
|
|
□ Background of the Symposium |
The China Beijing International High-tech
Industries Week ("the International Week") is
held every May in Beijing. It is jointly hosted by the
Ministry of Science and Technology, the Ministry of Foreign
Trade and Economic Cooperation, the Ministry of Education,
the Ministry of Information Industry, China Council for
the Promotion of International Trade and the Beijing Municipal
Government.
The International Week offers high-tech trade exhibitions,
feature presentations, and high-tech trade talks, highlighting
the current status and achievements in the high-tech industry
in such areas as internet technology, electronics, communication,
bio-engineering, health and drugs, environmental protection,
new materials and new energy.
With the successful completion of the past four sessions,
the International Week has grown into a world-class high-tech
conference. More than 1 million guests representing thousands
of famous enterprises participated in the past four sessions,
which achieved a total turnover of tens of billion dollars'
worth of products and services. It has attracted extensive
concern and wide coverage by more than 1,000 famous media
organizations.
The 5th International Week and China Beijing International
Hi-tech Industries Expo will be the first international
activity of its kind since China's accession to the WTO
and its successful bidding for the 2008 Olympics. Both
Chinese and foreign political dignitaries will participate
in the event. Famous foreign and domestic enterprises
will gather again in Beijing.
The year of 2002 will be the first year after China's
accession to the WTO, and consequently, every industry
and sector are faced with challenges and opportunities
brought by globalization. The development of China's health,
drug and social securtiy sector, in particular, is expected
to experience tremendous shock and influence from related
international sectors as well as unprecedented reforms.
The goal for China's health, drug and social security
departments and enterprises in the 21st century is to
integrate its system into the international market and
make greater achievements. Evidently, for China's health,
drug and social security system, the policy research,
development strategy, experience and opinions, high-tech
development and exchange will be the special focus and
concern for the medicare and drug administration departments,
Chinese enterprises, foreign investment enterprises in
China, international health and drug, as well as insurance
sectors.
In view of the above factors, the 5th China Beijing International
High-tech Industries Week and the China Beijing International
Sci-tech Industries Expo will hold the Symposium on WTO
and the Development of China's Health, Drug and Social
Security, in an effort to provide an opportunity for world-wide
colleagues to discuss and exchange information and technology,
and in turn promote international cooperation and development
in China's health, drug and social security sector.
|
|
| □
Themes and Format |
This symposium is the first
of its kind held in the Beijing International High-tech
Industries Week after China's accession to the WTO. Delegates
are to make feature presentations and seminars as to the
trends of China's health, drug and social security policies,
as well as international standard practices.
1. Feature presentations
·Guest
speakers
-Official representatives
from Chinese government administrative organs in related
areas
-Offical representatives
from overseas government administrative organs in related
areas
-Chinese specialists
in related areas
-Overseas specialists
in related areas
·Proposed
themes
-Thoughts on
formulating basic medi-care catalog after China's accession
to the WTO
-Prospects of
the development of domestic and international basic medi-care
and commercial medicare and its impacts
-The application
of information technology in the Chinese social security
system
-The information
management in the Chinese medicare system
-Market operation
of social security funds
-The impact of
commercial medicare on prescription drugs after China's
accession to the WTO
-The relationship
between foreign e-commerce in health & drug and the
reforms in China's drug distribution system
-The administration
of drug quality and classification
-Policies on
drug patent protection and administrative protection
-The quota for
drugs in medicare
-WTO and the
development of GMP in China
-Related policies
on centralized vendor bidding and procurement of drugs
-Detailed implementation
rules of the new Drugs Act after China's accession to
the WTO
-The support
of prescription drugs data to the fixing of insurance
The impact of insurance drug catalog on the pricing of
drugs by the government
·Presentation
format
The presentations will be independently
made by the guest speakers, who will have the final say
in the presentation topics.
2. Elite in Focus (exclusive to
diamond sponsors)
·Guest
speakers
-Representatives
from related Chinese businesses
-Representatives
from related overseas businesses
·Proposed
themes
-Marketing strategy
for health and pharmaceutical enterprises at home and
abroad
-Quality Control
of Drugs
-Enterprise Culture
·Presentation
format
The presentations will be independently
made by the guest speakers, who will have the final say
in the presentation topics.
Presentations are to be made either
independently or in groups, and the topics are to be finally
determined by the guest speakers. The symposium will invite
2 to 3 representatives from related businesses at home
and abroad to participate in "Elite in Focus" activites
and make special presentations on certain topics.
3. Meetings on specialized topics
·Guest
speakers
-Official representatives
from Chinese government administrative departments in
related areas
·Proposed
themes
-Business opportunities
for Chinese traditional medicine enterprises in international
health and pharmaceutical market
-Development
strategies for domestic health and pharmaceutical enterprises
after China's accession to the WTO
-Perspectives
of international multi-center clinical research for new
drugs in the registration and administration of Chinese
drugs after its accession to the WTO
·Presentation
format
Delegates may put questions to
the officials after they complete their presentations.
The topics can be determined with reference to the topics
in the feature presentations. The guest speakers have
the final say with respect to the above-listed topics.
4. Seminar presentations
·Guest
speakers
-Chinese specialists
in related areas
-Overseas specialists
in related areas
-Representatives
from related Chinese businesses
-Representatives
from related overseas businesses
·Proposed
themes
-The pricing
of foreign drugs
-Drug patent
protection
-Drug bidding
and procurement
-The determination
of catalog for medicare drugs
-Development
prospects of Chinese traditional medicine
·Presentation
format
The symposium will invite scholars
and business representatives to hold discussions about
the topics that have been decided on. Participants can
also air their viewpoints or make speeches with respect
to the concerned topics, which will be decided by the
guest speakers. The symposium will compile all of the
speeches and presentations made and submit to the related
authorities. If you have new ideas as to the topics listed
above, please inform us and we will try to make necessary
arrangements. We firmly believe that your participation
will make this symposium more exciting. |
|
|
|
| □
Organizations and guests to be invited |
·Mr. Wu Jieping, Vice chairman
of the Standing Committee of the National People's Congress
of PRC
·Mr. Wang Dongjin, Deputy
Minister of the Ministry of Labor and Social Security
·Mr. Zhu Qingsheng, Deputy
Minister of the Ministry of Public Health
·Mr. Zheng Xiaoyu, Director
of the State Drug Administration
·Chief, Policy Research
Office of the State Council of PRC
·Chief, Division of Price
of the State Development Planning Commission of PRC
·Chief, Division of Medical
Affairs of the Ministry of Public Health of PRC
·Chief,
Division of Planning and Finance of the Ministry of
Public Health of PRC
·Director, Hygiene
Economics Research Institute of the Ministry of Public
Health of PRC
·Chief, Division of Medical
Insurance of the Ministry of Labor and Social Security
of PRC
·Chief, Center of Social
Security Administration of the Ministry of Labor and
Social Security of PRC
·Chief, State Drug Administration
of PRC
·Chief, Divison of Security
Supervison of State Drug Administration of PRC
·Chief, Divison of Registration
of State Drug Administration of PRC
·Director, Center of Medical
Insurance Administration of Shanghai Municipality
·Director, Center of Medicare
Information of Shanghai Municipality
·Chief, International
Insurance Companies in China
·Chief, Foreign Health
and Pharmaceutical Enterprises
·Official, World Health
Organization (WHO)
·Official, Food and Drug
Administration (FDA)
·Official, Health Maintenance
Organization (HMO)
·Official, U.S. Insurance
Association
·Official, French Pharmaceutical
Association
·Official, Related organization
from the European Union
·Experts, Related areas
at home and abroad
·Chiefs, Chinese Pharmaceutical
Enterprises
·Chiefs, Foreign Pharmaceutical
Enterprises in China
|
|
|
|
| □
Special Features |
1、First-time adoption of interactive dialog
in the discussion of issues in focus.
Note：Issues in focus--Catalog of
basic medicare; Drug prices; Drug patents; Centralized
vendor bidding and procurement of drugs
2、First-time high-level symposium in the "International
Week" activities.
Note：Highest ranking official to
attend the symposium——
Mr. Wu Jieping, Vice Chairman, Standing
Committee of National People's Congress of PRC
3、First-time joint presence of leaders at the symposium
for the International Week from the Ministry of Labor
and Social Security, the Ministry of Public Health,
and the State Drug Administration
Note：Leaders to attend the symposium——
Mr. Wang Dongjin, Deputy Minister
of the Ministry of Labor and Social Security, Mr. Zhu
Qingsheng, Deputy Minister of the Ministry of Public
Health, Ms. Zheng Xiaoyu, Director of the State Drug
Administration
N.B.: There will be live media
coverage by influential international media at the time
of conference.
|
|
|
|
|
|
